Hepatitis B ultrasound: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
| Line 26: | Line 26: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:FinalQCRequired]] | [[Category:FinalQCRequired]] | ||
Revision as of 17:55, 18 September 2017
|
Hepatitis B |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis B ultrasound On the Web |
|
American Roentgen Ray Society Images of Hepatitis B ultrasound |
|
Risk calculators and risk factors for Hepatitis B ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
The ultrasound may be used as a screening tool in patients with chronic hepatitis for the early detection of hepatic cirrhosis. HBsAg carriers with cirrhosis should be echographically evaluated every 6 months.
Ultrasound
The following findings may be identified:[1]
- Coarse echogenicity
- Segmental hypertrophy with nodular appearance of the liver
- Portal hypertension:
HBsAg carriers should have regular serial serum alpha-fetoprotein determinations, and ultrasound examinations for those above 40 years of age (with 6 month intervals).[2]
Both these tests are recommended to be repeated regularly, for all HBsAg carriers with cirrhosis.[1]
References
- ↑ 1.0 1.1 "Hepatitis D" (PDF).
- ↑ World Health Organization, Guidelines for the Prevention, Care, and Treatment of persons with chronic Hepatitis B Infection. (March 2015). http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf Accessed on October 4th, 2016